시장보고서
상품코드
1193210

중대질병보험 시장 : 용도별(암, 심장 발작, 뇌졸중, 기타), 보험료 형태별(월차, 분기, 반기, 연차), 최종 사용자별(개인, 기업) - 세계 기회 분석 및 산업 예측(2021-2031년)

Critical Illness Insurance Market By Application (Cancer, Heart Attack, Stroke, Others), By Premium Mode (Monthly, Quarterly, Half Yearly, Yearly), By End User (Individual, Businesses): Global Opportunity Analysis and Industry Forecast, 2021-2031

발행일: | 리서치사: Allied Market Research | 페이지 정보: 영문 345 Pages | 배송안내 : 2-3일 (영업일 기준)

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

중대질병보험은 신부전, 심장 질환, 암 등 생명을 위협하는 다양한 건강 상태에 대해 피보험자에게 경제적 보장을 제공합니다.

심각한 질병 보험에는 피보험자가 지정된 질병으로 진단될 때 지급되는 임시금이 포함됩니다.

건강에 해로운 생활 습관으로 인한 건강 문제의 증가는 신부전, 심장 발작, 암 등의 심각한 질병을 일으켜 소비자들 사이에서 중대질병보험에 대한 수요가 높아지고 있습니다. 또한 중대한 질병 보험의 이점에 대한 소비자의 인식이 높아지고 있는 것도 시장의 큰 촉진 요인이 되고 있습니다. 게다가, 보험에 가입하지 않은 경우, 치료비가 고액이 될 가능성이 있기 때문에, 중대질병보험의 이용을 선택하는 소비자도 늘고 있습니다. 이들은 심각한 질병 보험 시장의 성장을 뒷받침하는 요인의 일부입니다. 그러나 보험료가 고액인 것은 시장의 성장을 방해하는 큰 요인이 되고 있습니다. 이에 대해 의료비 환불이나 수술이나 치료에 드는 고액의 비용을 걱정하지 않고 최고의 병원에서 현금이 없는 치료를 받을 수 있는 보험이 제공하는 부드러운 체험은 향후 수년간 유리한 성장 기회 가져올 것으로 예상됩니다.

목차

제1장 소개

제2장 주요 요약

제3장 시장 개요

  • 시장의 정의와 범위
  • 주요 조사 결과
    • 주요 투자 포켓
  • Porter's Five Forces 분석
  • 주요 기업의 포지셔닝
  • 시장 역학
    • 촉진 요인
    • 억제 요인
    • 기회
  • COVID-19 시장에 미치는 영향 분석

제4장 중대질병보험 시장 : 적용 분야별

  • 개요
    • 시장 규모 및 예측
  • 암(캔서
    • 주요 시장 동향, 성장 요인, 기회
    • 시장 규모·예측 : 지역별
    • 시장 분석 : 국가별
  • 심장 발작
    • 주요 시장 동향, 성장 요인, 기회
    • 시장 규모·예측 : 지역별
    • 시장 분석 : 국가별
  • 뇌졸중
    • 주요 시장 동향, 성장 요인, 기회
    • 시장 규모·예측 : 지역별
    • 시장 분석 : 국가별
  • 기타
    • 주요 시장 동향, 성장 요인, 기회
    • 시장 규모·예측 : 지역별
    • 시장 분석 : 국가별

제5장 중대질병보험 시장 : 프리미엄 모드별

  • 개요
    • 시장 규모·예측
  • 월차
    • 주요 시장 동향, 성장 요인과 기회
    • 시장 규모·예측 : 지역별
    • 시장 분석 : 국가별 분석
  • 분기마다
    • 주요 시장 동향, 성장 요인과 기회
    • 시장 규모·예측 : 지역별
    • 시장 분석 : 국가별
  • 반년마다
    • 주요 시장 동향, 성장 요인과 기회
    • 시장 규모·예측 : 지역별
    • 시장 분석 : 국가별
  • 매년
    • 주요 시장 동향, 성장 요인, 기회
    • 시장 규모·예측 : 지역별
    • 시장 분석 : 국가별

제6장 중대질병보험 시장 : 최종 사용자별

  • 개요
    • 시장 규모 및 예측
  • 개별
    • 주요 시장 동향, 성장 요인과 기회
    • 시장 규모·예측 : 지역별
    • 시장 분석 : 국가별 분석
  • 사업자별
    • 주요 시장 동향, 성장 요인, 기회
    • 시장 규모·예측 : 지역별
    • 시장 분석 : 국가별

제7장 중대질병보험 시장 : 지역별

  • 개요
    • 시장 규모·예측
  • 북미
    • 주요 동향과 기회
    • 북미의 시장 규모·예측 : 용도별
    • 북미 시장 규모·예측 : 프리미엄 모드별
    • 북미 시장 규모·예측 : 최종 사용자별
    • 북미 시장 규모·예측 : 국가별
      • 미국
      • 캐나다
  • 유럽
    • 주요 동향과 기회
    • 유럽 시장 규모·예측 : 용도별
    • 유럽의 시장 규모·예측 : 프리미엄 모드별
    • 유럽 시장 규모·예측 : 최종 사용자별
    • 유럽 시장 규모·예측 : 국가별
      • 영국
      • 독일
      • 프랑스
      • 이탈리아
      • 스페인
      • 네덜란드
      • 기타 유럽
  • 아시아태평양
    • 주요 동향과 기회
    • 아시아태평양의 시장 규모·예측 : 용도별
    • 아시아태평양의 시장 규모·예측 : 프리미엄 모드별
    • 아시아태평양의 시장 규모·예측 : 최종 사용자별
    • 아시아태평양의 시장 규모·예측 : 국가별
      • 중국
      • 인도
      • 일본
      • 호주
      • 싱가포르
      • 기타 아시아태평양
  • LAMEA
    • 주요 동향과 기회
    • LAMEA의 시장 규모·예측 : 용도별
    • LAMEA의 시장 규모·예측 : 프리미엄 모드별
    • LAMEA의 시장 규모·예측 : 엔드유저별
    • LAMEA의 시장 규모·예측 : 국가별
      • 라틴 아메리카
      • 중동
      • 아프리카

제8장 기업 정세

  • 소개
  • 주요 성공 전략
  • 주요 10개사의 제품 매핑
  • 경쟁 대시보드
  • 경합의 히트 맵
  • 주요 발전

제9장 기업 프로필

  • Aegon
  • AFLAC INCORPORATED
  • Allianz Care
  • American International Group, Inc.
  • Aviva
  • AXA
  • Bajaj Allianz General Insurance Co. Ltd.
  • Cigna
  • Future Generali India Insurance Company Ltd.
  • Legal & General Group plc
  • Liberty Mutual Insurance
  • MetLife Services and Solutions, LLC.
  • Royal London
  • Sun Life Assurance Company of Canada
  • United HealthCare Services, Inc.
  • Modern Insurance Agency, Inc.
  • Plum Benefits Private Limited
ksm 23.03.27

The critical illness insurance cover provides the insured with financial security against various life-threatening health conditions such as kidney failures, cardiovascular diseases, and cancer. Critical illness insurance cover includes a lump sum payment in case the insured is diagnosed with a listed illness.

Rise in number of health issues due to unhealthy lifestyle of people causes serious illness such as kidney failures, heart attack, cancer and other such serious illness have increased the demand for critical illness insurance coverage among consumers. In addition, rise in awareness about the benefits of a critical illness insurance coverage among consumers is a major driving factor for the market. Moreover, the cost of treatment without having an insurance coverage may lead to huge medical bills for which customers opt for the critical illness insurance. These are some of the factors propelling the growth of the critical illness insurance market. However, high amount of premium for the critical illness insurance is a major factor limiting the growth of the market. On the contrary, smooth experience offered by the insurance coverage pertaining to reimbursement of medical bills and cashless treatments at best hospitals without the worry of high fees charged for operation and treatments is expected to provide lucrative growth opportunities in the coming years.

The critical illness insurance market is segmented on the basis of application, premium mode, end user, and region. By application, it is classified into cancer, heart attack, stroke, and others. By premium mode, it is categorized into monthly, quarterly, half yearly, and yearly. By application, it is bifurcated into individual, and businesses. The businesses segment is further sub segmented into group policies and individual policies. The group policies segment is further divided into simplified issue policies, and fully underwritten policies. By region, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The report analyzes the profiles of key players operating in the critical illness insurance market such as Aegon, AFLAC INCORPORATED, Allianz Care, American International Group, Inc., Aviva, AXA Hong Kong, Bajaj Allianz General Insurance Co. Ltd., Cigna, Future Generali India Insurance Company Ltd., Legal & General Group plc, Liberty Mutual Insurance, MetLife Services and Solutions, LLC., Royal London, Sun Life Assurance Company of Canada, United HealthCare Services, Inc., Modern Insurance Agency, Inc., and Plum Benefits Private Limited. These players have adopted various strategies to increase their market penetration and strengthen their position in the critical illness insurance industry.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the critical illness insurance market analysis from 2021 to 2031 to identify the prevailing critical illness insurance market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the critical illness insurance market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global critical illness insurance market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Application

  • Others
  • Cancer
  • Heart Attack
  • Stroke

By Premium Mode

  • Monthly
  • Quarterly
  • Half Yearly
  • Yearly

By End User

  • Individual
  • Businesses

By Region

  • North America
    • U.S.
    • Canada
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Netherlands
    • Rest Of Europe
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • Singapore
    • Rest Of Asia-Pacific
  • LAMEA
    • Latin America
    • Middle East
    • Africa
  • Key Market Players
    • Aegon
    • AFLAC INCORPORATED
    • Allianz Care
    • American International Group, Inc.
    • Aviva
    • AXA
    • Bajaj Allianz General Insurance Co. Ltd.
    • Cigna
    • Future Generali India Insurance Company Ltd.
    • Legal & General Group plc
    • Liberty Mutual Insurance
    • MetLife Services and Solutions, LLC.
    • Royal London
    • Sun Life Assurance Company of Canada
    • United HealthCare Services, Inc.
    • Modern Insurance Agency, Inc.
    • Plum Benefits Private Limited

TABLE OF CONTENTS

CHAPTER 1:INTRODUCTION

  • 1.1.Report description
  • 1.2.Key market segments
  • 1.3.Key benefits to the stakeholders
  • 1.4.Research Methodology
    • 1.4.1.Secondary research
    • 1.4.2.Primary research
    • 1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

  • 2.1.Key findings of the study
  • 2.2.CXO Perspective

CHAPTER 3:MARKET OVERVIEW

  • 3.1.Market definition and scope
  • 3.2.Key findings
    • 3.2.1.Top investment pockets
  • 3.3.Porter's five forces analysis
  • 3.4.Top player positioning
  • 3.5.Market dynamics
    • 3.5.1.Drivers
    • 3.5.2.Restraints
    • 3.5.3.Opportunities
  • 3.6.COVID-19 Impact Analysis on the market

CHAPTER 4: CRITICAL ILLNESS INSURANCE MARKET, BY APPLICATION

  • 4.1 Overview
    • 4.1.1 Market size and forecast
  • 4.2 Cancer
    • 4.2.1 Key market trends, growth factors and opportunities
    • 4.2.2 Market size and forecast, by region
    • 4.2.3 Market analysis by country
  • 4.3 Heart Attack
    • 4.3.1 Key market trends, growth factors and opportunities
    • 4.3.2 Market size and forecast, by region
    • 4.3.3 Market analysis by country
  • 4.4 Stroke
    • 4.4.1 Key market trends, growth factors and opportunities
    • 4.4.2 Market size and forecast, by region
    • 4.4.3 Market analysis by country
  • 4.5 Others
    • 4.5.1 Key market trends, growth factors and opportunities
    • 4.5.2 Market size and forecast, by region
    • 4.5.3 Market analysis by country

CHAPTER 5: CRITICAL ILLNESS INSURANCE MARKET, BY PREMIUM MODE

  • 5.1 Overview
    • 5.1.1 Market size and forecast
  • 5.2 Monthly
    • 5.2.1 Key market trends, growth factors and opportunities
    • 5.2.2 Market size and forecast, by region
    • 5.2.3 Market analysis by country
  • 5.3 Quarterly
    • 5.3.1 Key market trends, growth factors and opportunities
    • 5.3.2 Market size and forecast, by region
    • 5.3.3 Market analysis by country
  • 5.4 Half Yearly
    • 5.4.1 Key market trends, growth factors and opportunities
    • 5.4.2 Market size and forecast, by region
    • 5.4.3 Market analysis by country
  • 5.5 Yearly
    • 5.5.1 Key market trends, growth factors and opportunities
    • 5.5.2 Market size and forecast, by region
    • 5.5.3 Market analysis by country

CHAPTER 6: CRITICAL ILLNESS INSURANCE MARKET, BY END USER

  • 6.1 Overview
    • 6.1.1 Market size and forecast
  • 6.2 Individual
    • 6.2.1 Key market trends, growth factors and opportunities
    • 6.2.2 Market size and forecast, by region
    • 6.2.3 Market analysis by country
  • 6.3 Businesses
    • 6.3.1 Key market trends, growth factors and opportunities
    • 6.3.2 Market size and forecast, by region
    • 6.3.3 Market analysis by country

CHAPTER 7: CRITICAL ILLNESS INSURANCE MARKET, BY REGION

  • 7.1 Overview
    • 7.1.1 Market size and forecast
  • 7.2 North America
    • 7.2.1 Key trends and opportunities
    • 7.2.2 North America Market size and forecast, by Application
    • 7.2.3 North America Market size and forecast, by Premium Mode
    • 7.2.4 North America Market size and forecast, by End User
    • 7.2.5 North America Market size and forecast, by country
      • 7.2.5.1 U.S.
      • 7.2.5.1.1 Market size and forecast, by Application
      • 7.2.5.1.2 Market size and forecast, by Premium Mode
      • 7.2.5.1.3 Market size and forecast, by End User
      • 7.2.5.2 Canada
      • 7.2.5.2.1 Market size and forecast, by Application
      • 7.2.5.2.2 Market size and forecast, by Premium Mode
      • 7.2.5.2.3 Market size and forecast, by End User
  • 7.3 Europe
    • 7.3.1 Key trends and opportunities
    • 7.3.2 Europe Market size and forecast, by Application
    • 7.3.3 Europe Market size and forecast, by Premium Mode
    • 7.3.4 Europe Market size and forecast, by End User
    • 7.3.5 Europe Market size and forecast, by country
      • 7.3.5.1 UK
      • 7.3.5.1.1 Market size and forecast, by Application
      • 7.3.5.1.2 Market size and forecast, by Premium Mode
      • 7.3.5.1.3 Market size and forecast, by End User
      • 7.3.5.2 Germany
      • 7.3.5.2.1 Market size and forecast, by Application
      • 7.3.5.2.2 Market size and forecast, by Premium Mode
      • 7.3.5.2.3 Market size and forecast, by End User
      • 7.3.5.3 France
      • 7.3.5.3.1 Market size and forecast, by Application
      • 7.3.5.3.2 Market size and forecast, by Premium Mode
      • 7.3.5.3.3 Market size and forecast, by End User
      • 7.3.5.4 Italy
      • 7.3.5.4.1 Market size and forecast, by Application
      • 7.3.5.4.2 Market size and forecast, by Premium Mode
      • 7.3.5.4.3 Market size and forecast, by End User
      • 7.3.5.5 Spain
      • 7.3.5.5.1 Market size and forecast, by Application
      • 7.3.5.5.2 Market size and forecast, by Premium Mode
      • 7.3.5.5.3 Market size and forecast, by End User
      • 7.3.5.6 Netherlands
      • 7.3.5.6.1 Market size and forecast, by Application
      • 7.3.5.6.2 Market size and forecast, by Premium Mode
      • 7.3.5.6.3 Market size and forecast, by End User
      • 7.3.5.7 Rest of Europe
      • 7.3.5.7.1 Market size and forecast, by Application
      • 7.3.5.7.2 Market size and forecast, by Premium Mode
      • 7.3.5.7.3 Market size and forecast, by End User
  • 7.4 Asia-Pacific
    • 7.4.1 Key trends and opportunities
    • 7.4.2 Asia-Pacific Market size and forecast, by Application
    • 7.4.3 Asia-Pacific Market size and forecast, by Premium Mode
    • 7.4.4 Asia-Pacific Market size and forecast, by End User
    • 7.4.5 Asia-Pacific Market size and forecast, by country
      • 7.4.5.1 China
      • 7.4.5.1.1 Market size and forecast, by Application
      • 7.4.5.1.2 Market size and forecast, by Premium Mode
      • 7.4.5.1.3 Market size and forecast, by End User
      • 7.4.5.2 India
      • 7.4.5.2.1 Market size and forecast, by Application
      • 7.4.5.2.2 Market size and forecast, by Premium Mode
      • 7.4.5.2.3 Market size and forecast, by End User
      • 7.4.5.3 Japan
      • 7.4.5.3.1 Market size and forecast, by Application
      • 7.4.5.3.2 Market size and forecast, by Premium Mode
      • 7.4.5.3.3 Market size and forecast, by End User
      • 7.4.5.4 Australia
      • 7.4.5.4.1 Market size and forecast, by Application
      • 7.4.5.4.2 Market size and forecast, by Premium Mode
      • 7.4.5.4.3 Market size and forecast, by End User
      • 7.4.5.5 Singapore
      • 7.4.5.5.1 Market size and forecast, by Application
      • 7.4.5.5.2 Market size and forecast, by Premium Mode
      • 7.4.5.5.3 Market size and forecast, by End User
      • 7.4.5.6 Rest of Asia-Pacific
      • 7.4.5.6.1 Market size and forecast, by Application
      • 7.4.5.6.2 Market size and forecast, by Premium Mode
      • 7.4.5.6.3 Market size and forecast, by End User
  • 7.5 LAMEA
    • 7.5.1 Key trends and opportunities
    • 7.5.2 LAMEA Market size and forecast, by Application
    • 7.5.3 LAMEA Market size and forecast, by Premium Mode
    • 7.5.4 LAMEA Market size and forecast, by End User
    • 7.5.5 LAMEA Market size and forecast, by country
      • 7.5.5.1 Latin America
      • 7.5.5.1.1 Market size and forecast, by Application
      • 7.5.5.1.2 Market size and forecast, by Premium Mode
      • 7.5.5.1.3 Market size and forecast, by End User
      • 7.5.5.2 Middle East
      • 7.5.5.2.1 Market size and forecast, by Application
      • 7.5.5.2.2 Market size and forecast, by Premium Mode
      • 7.5.5.2.3 Market size and forecast, by End User
      • 7.5.5.3 Africa
      • 7.5.5.3.1 Market size and forecast, by Application
      • 7.5.5.3.2 Market size and forecast, by Premium Mode
      • 7.5.5.3.3 Market size and forecast, by End User

CHAPTER 8: COMPANY LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top winning strategies
  • 8.3. Product Mapping of Top 10 Player
  • 8.4. Competitive Dashboard
  • 8.5. Competitive Heatmap
  • 8.6. Key developments

CHAPTER 9: COMPANY PROFILES

  • 9.1 Aegon
    • 9.1.1 Company overview
    • 9.1.2 Company snapshot
    • 9.1.3 Operating business segments
    • 9.1.4 Product portfolio
    • 9.1.5 Business performance
    • 9.1.6 Key strategic moves and developments
  • 9.2 AFLAC INCORPORATED
    • 9.2.1 Company overview
    • 9.2.2 Company snapshot
    • 9.2.3 Operating business segments
    • 9.2.4 Product portfolio
    • 9.2.5 Business performance
    • 9.2.6 Key strategic moves and developments
  • 9.3 Allianz Care
    • 9.3.1 Company overview
    • 9.3.2 Company snapshot
    • 9.3.3 Operating business segments
    • 9.3.4 Product portfolio
    • 9.3.5 Business performance
    • 9.3.6 Key strategic moves and developments
  • 9.4 American International Group, Inc.
    • 9.4.1 Company overview
    • 9.4.2 Company snapshot
    • 9.4.3 Operating business segments
    • 9.4.4 Product portfolio
    • 9.4.5 Business performance
    • 9.4.6 Key strategic moves and developments
  • 9.5 Aviva
    • 9.5.1 Company overview
    • 9.5.2 Company snapshot
    • 9.5.3 Operating business segments
    • 9.5.4 Product portfolio
    • 9.5.5 Business performance
    • 9.5.6 Key strategic moves and developments
  • 9.6 AXA
    • 9.6.1 Company overview
    • 9.6.2 Company snapshot
    • 9.6.3 Operating business segments
    • 9.6.4 Product portfolio
    • 9.6.5 Business performance
    • 9.6.6 Key strategic moves and developments
  • 9.7 Bajaj Allianz General Insurance Co. Ltd.
    • 9.7.1 Company overview
    • 9.7.2 Company snapshot
    • 9.7.3 Operating business segments
    • 9.7.4 Product portfolio
    • 9.7.5 Business performance
    • 9.7.6 Key strategic moves and developments
  • 9.8 Cigna
    • 9.8.1 Company overview
    • 9.8.2 Company snapshot
    • 9.8.3 Operating business segments
    • 9.8.4 Product portfolio
    • 9.8.5 Business performance
    • 9.8.6 Key strategic moves and developments
  • 9.9 Future Generali India Insurance Company Ltd.
    • 9.9.1 Company overview
    • 9.9.2 Company snapshot
    • 9.9.3 Operating business segments
    • 9.9.4 Product portfolio
    • 9.9.5 Business performance
    • 9.9.6 Key strategic moves and developments
  • 9.10 Legal & General Group plc
    • 9.10.1 Company overview
    • 9.10.2 Company snapshot
    • 9.10.3 Operating business segments
    • 9.10.4 Product portfolio
    • 9.10.5 Business performance
    • 9.10.6 Key strategic moves and developments
  • 9.11 Liberty Mutual Insurance
    • 9.11.1 Company overview
    • 9.11.2 Company snapshot
    • 9.11.3 Operating business segments
    • 9.11.4 Product portfolio
    • 9.11.5 Business performance
    • 9.11.6 Key strategic moves and developments
  • 9.12 MetLife Services and Solutions, LLC.
    • 9.12.1 Company overview
    • 9.12.2 Company snapshot
    • 9.12.3 Operating business segments
    • 9.12.4 Product portfolio
    • 9.12.5 Business performance
    • 9.12.6 Key strategic moves and developments
  • 9.13 Royal London
    • 9.13.1 Company overview
    • 9.13.2 Company snapshot
    • 9.13.3 Operating business segments
    • 9.13.4 Product portfolio
    • 9.13.5 Business performance
    • 9.13.6 Key strategic moves and developments
  • 9.14 Sun Life Assurance Company of Canada
    • 9.14.1 Company overview
    • 9.14.2 Company snapshot
    • 9.14.3 Operating business segments
    • 9.14.4 Product portfolio
    • 9.14.5 Business performance
    • 9.14.6 Key strategic moves and developments
  • 9.15 United HealthCare Services, Inc.
    • 9.15.1 Company overview
    • 9.15.2 Company snapshot
    • 9.15.3 Operating business segments
    • 9.15.4 Product portfolio
    • 9.15.5 Business performance
    • 9.15.6 Key strategic moves and developments
  • 9.16 Modern Insurance Agency, Inc.
    • 9.16.1 Company overview
    • 9.16.2 Company snapshot
    • 9.16.3 Operating business segments
    • 9.16.4 Product portfolio
    • 9.16.5 Business performance
    • 9.16.6 Key strategic moves and developments
  • 9.17 Plum Benefits Private Limited
    • 9.17.1 Company overview
    • 9.17.2 Company snapshot
    • 9.17.3 Operating business segments
    • 9.17.4 Product portfolio
    • 9.17.5 Business performance
    • 9.17.6 Key strategic moves and developments
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제